Maravai (MRVI) brokered sale notice: 25,000 Class A shares via Fidelity
Rhea-AI Filing Summary
Maravai LifeSciences (MRVI) filed a Form 144 reporting an intent to sell 25,000 shares of Class A common stock through Fidelity Brokerage Services LLC on NASDAQ. The filing lists prior acquisitions of Class A shares by vesting and ESPP purchases on 03/15/2024, 04/30/2024, 10/31/2024, and 01/15/2025 totaling the disclosed prior receipts.
Positive
- None.
Negative
- None.
Insights
Form 144 flags a planned sale of 25,000 Class A shares via a broker.
The filing names Fidelity Brokerage Services LLC as the broker and lists 25,000 Class A shares with a transaction date reference of 06/09/2026. This is a routine notice required for certain restricted or control securities disposed of in reliance on Rule 144.
Future filings will confirm actual sale execution and proceeds; cash‑flow treatment is not stated in the provided excerpt.